Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Return on Sales [ROS] (2015 - 2026)

Updated

Cocrystal Pharma's Return on Sales [ROS] came in at -3032.38% for Q2 2026, down 1985.27 percentage points from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cocrystal Pharma reported Return on Sales [ROS] of -760.72%; for FY2020, it was -475.97%, up 261.48 percentage points from FY2019.

  • Going back by year, Return on Sales [ROS] was -737.45% in FY2019.
  • The Q2 2026 figure represents the lowest quarterly Return on Sales [ROS] since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Cocrystal Pharma 16.00 Mn -5.91 Mn - -3,032.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,032.38%
Mar 31, 2026 -1,047.11%
Dec 31, 2020 -287.45%
Sep 30, 2020 -553.99%
Jun 30, 2020 -622.74%
Mar 31, 2020 -425.38%
Dec 31, 2019 -11,921.64%
Sep 30, 2019 -367.48%
Jun 30, 2019 -261.82%
Mar 31, 2019 56.66%
Sep 30, 2015 -14,958.33%
API Access

Cocrystal Pharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=COCP&period=max&api_key=YOUR_API_KEY